2025-03-30Niranjan Ghatule
In a move that could disrupt the global pharmaceutical supply chain, the Trump administration is reportedly considering imposing tariffs on pharmaceutical imports, including generic drugs from India. If implemented, such tariffs could significantly impact Indian pharmaceutical companies, many of which rely on the U.S. as their largest market.
View more
Your experience on this site will be improved by allowing cookies
Cookie Policy
